Clinical Trial Update: Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

View source ↗

Summary

A completed clinical trial comparing TNF inhibitors and tofacitinib in earlier lines of therapy and as monotherapy for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TNF inhibitors
• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis Rheumatoid | Status: COMPLETED | Results posted: 2024-04-12